The bottom line seems to be yes, genetic testing for inherited mutations may help tailor treatment for all with advanced or metastatic cancer.
The bottom line seems to be yes, genetic testing for inherited mutations may help tailor treatment for all with advanced or metastatic cancer.
In a study of nearly 12,000 patients with many kinds of metastatic cancers, eight percent of people had an inherited mutation in a cancer gene that qualified them for gene-directed treatment approved by the FDA or for participation in a clinical trial. Most were unaware of their inherited mutation and had not received gene-directed treatment to which their tumor may have responded.
The study authors suggest that all people with advanced or metastatic cancer should have genetic testing to ensure that they have the best care for their cancer.
Read more about our review of this study and what if could mean for you or members of your family.
Patient Advocate Faces Thyroid Cancer Decades After Surviving Breast Cancer
September 5th 2023‘I feel like I've gone to continuing education classes as an advocate through reentering the health system in the cancer space,’ FORCE executive director and founder Sue Friedman, a breast cancer survivor who recently received a diagnosis of thyroid cancer, tells CURE.
Read More
Stepping Up Again for Hereditary Cancer Prevention
February 25th 2023On Feb. 6, HB 2783 was introduced into the Arizona House. Hopefully this bill will help address some of the issues surrounding genetic testing, genetic counseling, and insurance coverage for those who might be at risk for hereditary cancer. My wife died of a cancer that was totally preventable. Nobody should die of a preventable cancer.
Read More